Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Polymyxin B Sulfate: Precision Tool for Gram-Negative Infect
2026-04-22
Polymyxin B sulfate delivers reproducible, high-impact results in multidrug-resistant Gram-negative infection and immune modulation studies. This guide provides workflow-driven protocols, optimization strategies, and troubleshooting insights, leveraging APExBIO's rigorously benchmarked formulation.
-
6-Thioguanine Suppresses EV71 via BIRC3-Mediated Autophagy I
2026-04-22
This study demonstrates that 6-thioguanine (6-TG) significantly inhibits EV71 replication in vitro by targeting BIRC3-mediated autophagy in human intestinal cells. The findings highlight a novel antiviral mechanism for 6-TG, suggesting translational potential for enteroviral therapeutics and providing a foundation for further mechanistic and preclinical research.
-
Arachidonic Acid Supplementation Accelerates Vaccine-Induced
2026-04-21
This study demonstrates that dietary arachidonic acid (ARA) significantly enhances vaccine-induced neutralizing antibody production and protection against rabies infection in both mice and humans. Mechanistically, ARA is metabolized in lymph nodes to immune modulators such as prostaglandin I2, which upregulate B cell activation pathways, supporting its use as a dietary adjuvant for rapid and robust humoral immunity.
-
Neticonazole Hydrochloride: Advanced Protocols in Oncology a
2026-04-21
Explore how Neticonazole Hydrochloride serves as an imidazole antifungal with unique dual roles in cutaneous candidiasis and colorectal cancer research. This article delivers practical assay guidance, mechanistic insights, and protocol parameters for translational scientists.
-
D-Luciferin Potassium Salt: Elevating Bioluminescence Imagin
2026-04-20
D-Luciferin (potassium salt) delivers unmatched sensitivity and workflow efficiency for in vivo bioluminescence imaging and luciferase assays. APExBIO’s water-soluble formulation streamlines real-time tumor cell tracking and quantitative analysis, enabling breakthroughs in translational research.
-
Dabigatran Etexilate: Advances in Oral Anticoagulation Thera
2026-04-20
This review examines the pharmacological innovation of dabigatran etexilate as the first oral direct thrombin inhibitor for prevention of stroke and venous thromboembolism. The study highlights its predictable pharmacokinetics and lack of CYP450 metabolism, marking a significant advance over traditional therapies and impacting the design of drug-drug interaction studies.
-
A-769662: AMPK Activator for Advanced Metabolic Assays
2026-04-19
A-769662 stands out as a potent, reversible AMPK activator, enabling precise dissection of cellular energy regulation, fatty acid synthesis inhibition, and proteasome function. Its unique dual action and robust performance make it indispensable for metabolic disease and autophagy research.
-
SP600125 as a JNK Inhibitor: Applied Workflows & Troubleshoo
2026-04-18
SP600125 stands out as a highly selective, ATP-competitive JNK inhibitor, enabling precise mapping of JNK-regulated pathways in apoptosis, inflammation, and cytokine expression modulation. This guide delivers actionable protocols, advanced troubleshooting, and real-world insights tailored for high-impact research applications.
-
Substance P: Practical Guide for CNS & Inflammation Research
2026-04-17
Substance P (B6620) is a highly pure tachykinin neuropeptide widely used to model neurotransmission, pain signaling, and inflammation in preclinical research. This product is ideal for protocols requiring strict solubility, stability, and purity parameters but is not intended for diagnostic or medical use. Researchers should adhere closely to storage and handling guidelines to ensure experimental reproducibility.
-
Renal K+ Channel Blockade Alters Vascular Response in Sepsis
2026-04-16
This study investigates how blocking specific potassium channels in the kidney modifies the organ's vascular response to vasopressors during sepsis. The findings reveal that ATP-sensitive and calcium-activated K+ channel inhibition, especially during early sepsis, can worsen renal blood flow reduction when combined with norepinephrine or phenylephrine, underscoring the complexity of vascular regulation in septic shock.
-
iPSC Platforms Enable Precision Drug Prescreening in Ultrara
2026-04-15
This study presents a patient-specific iPSC-based platform for prescreening drug efficacy and safety in an ultrarare Leigh-like syndrome case with novel ECHS1 mutations. The approach demonstrates how individualized disease modeling can inform clinical trial selection and improve outcomes for patients with previously uncharacterized pathogenic variants.
-
Tofacitinib Citrate (CP-690550 citrate): Protocols & Immune
2026-04-14
Tofacitinib citrate (CP-690550 citrate) empowers precise dissection of immune regulation pathways and inflammatory disorder models. This article translates recent cardiovascular findings and laboratory best practices into actionable protocols and troubleshooting guidance for JAK-STAT pathway research.
-
FGFR–TGFβ–PI3K/AKT Crosstalk Regulates Periostin in HER2+ Br
2026-04-13
Labrèche et al. (2021) elucidate how periostin expression in HER2-positive breast cancer cells is intricately regulated by an interplay between FGFR, TGFβ, and PI3K/AKT signaling pathways. This work uncovers a context- and pathway-specific mechanism for periostin regulation, offering valuable insight for therapeutic strategy development in aggressive breast cancer subtypes.
-
SEMA3E Drives Beige Adipocyte Differentiation via β-Catenin
2026-04-13
This study reveals that SEMA3E is a critical regulator of beige adipocyte differentiation and thermogenesis in mice, acting through the Wnt/β-catenin signaling pathway. These insights advance the mechanistic understanding of adipose tissue plasticity and have implications for metabolic regulation research.
-
NADH in Mitochondrial Electron Transport Chain Research
2026-04-12
NADH is more than an energy coenzyme—its role as a metabolic probe and therapeutic target has enabled new frontiers in mitochondrial studies and photocatalytic cancer therapy. This article dissects practical workflows, advanced applications, and troubleshooting strategies using rigorously characterized NADH from APExBIO.